$0.26
arrow_drop_down4.00%Key Stats | |
---|---|
Open | $0.27 |
Prev. Close | $0.27 |
EPS | 268.14 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $4.55M |
LOW | HIGH | |
---|---|---|
Day Range | 0.24 | 0.27 |
52 Week Range | 0.21 | 128.00 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | 268.14 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Why Transcode Therapeutics (RNAZ) Stock Is Down 60% - Benzinga
Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
Successful Penny Stocks Trader Tips, 3 To Use
TransCode Therapeutics Reports 2023 Results; Provides Business Update